| 2025 | 2024 | 2023 | 2022 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 720,3 k € | -6.9% | 774,0 k € | -6.2% | 825,0 k € | -18.0% | 1,0 M € | +44.8% | 695,1 k € | +0.6% | 691,0 k € | +0.0% | 690,7 k € | +31.9% | 523,7 k € | +18.8% | 440,6 k € | -10.2% | 490,9 k € | -42.0% | 847,1 k € | +44.5% | 586,2 k € | +101.6% | 290,7 k € | -15.5% | 344,2 k € | +39.1% | 247,4 k € | -38.4% | 401,7 k € | +16.5% | 344,7 k € | |
| EBITDA | 713,9 k € | -7.1% | 768,4 k € | -6.3% | 820,5 k € | -18.2% | 1,0 M € | +44.6% | 693,4 k € | +0.6% | 689,3 k € | +0.0% | 689,0 k € | +32.1% | 521,7 k € | +18.9% | 438,7 k € | -10.3% | 488,9 k € | -42.1% | 844,2 k € | +44.3% | 584,9 k € | +102.3% | 289,1 k € | -15.6% | 342,5 k € | +39.4% | 245,6 k € | -38.6% | 400,2 k € | +16.7% | 342,9 k € | |
| Operating profit | 697,8 k € | -7.4% | 753,2 k € | -7.5% | 814,4 k € | -18.2% | 995,3 k € | +45.7% | 683,1 k € | +0.7% | 678,6 k € | +0.2% | 677,5 k € | +32.9% | 509,8 k € | +21.4% | 419,9 k € | -12.5% | 480,0 k € | -41.7% | 822,9 k € | +44.3% | 570,2 k € | +109.1% | 272,7 k € | -16.1% | 325,2 k € | +44.6% | 224,8 k € | -41.3% | 383,1 k € | +17.9% | 324,9 k € | |
| Profit/loss | 859,0 k € | +36.1% | 630,9 k € | -9.7% | 698,7 k € | -2.3% | 715,1 k € | +59.1% | 449,6 k € | +10.7% | 406,0 k € | -1.3% | 411,5 k € | +43.0% | 287,7 k € | +3.7% | 277,4 k € | -17.7% | 337,2 k € | -38.0% | 544,1 k € | +43.4% | 379,3 k € | +96.9% | 192,7 k € | -12.5% | 220,1 k € | +32.9% | 165,7 k € | -35.7% | 257,7 k € | +17.0% | 220,3 k € | |
| Equity | 5,9 M € | +17.1% | 5,0 M € | +14.4% | 4,4 M € | +18.9% | 3,7 M € | +82.3% | 2,0 M € | +4.5% | 1,9 M € | +26.5% | 1,5 M € | +36.7% | 1,1 M € | +34.5% | 833,1 k € | +49.9% | 555,7 k € | -4.3% | 580,8 k € | +33.0% | 436,7 k € | +661.0% | 57,4 k € | -81.8% | 314,7 k € | -60.4% | 794,6 k € | +26.3% | 629,0 k € | +69.4% | 371,3 k € | |
| Total assets | 6,1 M € | +18.7% | 5,1 M € | +15.2% | 4,4 M € | +11.2% | 4,0 M € | +67.0% | 2,4 M € | +0.6% | 2,4 M € | +22.3% | 1,9 M € | +36.5% | 1,4 M € | +18.9% | 1,2 M € | +34.4% | 888,6 k € | -25.0% | 1,2 M € | +42.3% | 833,4 k € | +18.8% | 701,3 k € | -34.9% | 1,1 M € | +19.1% | 903,9 k € | -9.9% | 1,0 M € | +23.6% | 811,8 k € | |
| Cash | 306,7 k € | -51.3% | 629,5 k € | +97.6% | 318,6 k € | -34.6% | 487,2 k € | -2.0% | 497,3 k € | +17.2% | 424,3 k € | +6.4% | 398,9 k € | +4.7% | 381,0 k € | +6.1% | 359,1 k € | +742.5% | 42,6 k € | -92.4% | 557,2 k € | +17.3% | 475,2 k € | +163.0% | 180,7 k € | +19.4% | 151,3 k € | +534.2% | 23,9 k € | -77.5% | 106,0 k € | -3.8% | 110,2 k € | |
| Debts | 169,8 k € | +119.5% | 77,4 k € | +105.0% | 37,7 k € | -87.0% | 289,8 k € | -16.4% | 346,6 k € | -17.8% | 421,8 k € | +6.1% | 397,5 k € | +39.7% | 284,6 k € | -19.3% | 352,5 k € | +5.9% | 332,7 k € | -44.6% | 600,4 k € | +51.3% | 396,7 k € | -36.7% | 626,2 k € | -17.4% | 757,9 k € | +663.8% | 99,2 k € | -72.4% | 358,9 k € | -16.9% | 431,9 k € | |
| Staff | 0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||||||||||||
Private limited company · Sint-Niklaas · incorporated on 09/09/1999 · 0,0 ETP
Private limited company profitable and well capitalised. Cash position declining (-51.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DR. DE MEESTER & DR. SERBRUYNS is a Private limited company incorporated in 1999. Its main activity is: Specialist medical practice activities. Its registered office is in Sint-Niklaas.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette